SL
Live price temporarily unavailable.
Price history
Simulations Plus Inc (SLP) is a Health Care company in the Russell 2000. Latest news and coverage below.
Simulations Plus Inc revenue & net income history (FY2016–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2016Aug 2016 | FY2017Aug 2017 | FY2018Aug 2018 | FY2019Aug 2019 | FY2020Aug 2020 | FY2021Aug 2021 | FY2022Aug 2022 | FY2023Aug 2023 | FY2024Aug 2024 | FY2025Aug 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $20.0M | $24.1M | $29.7M | $34.0M | $41.6M | $46.5M | $53.9M | $59.6M | $70.0M | $79.2M |
| Growth (year over year) | +9.1% | +20.9% | +22.9% | +14.5% | +22.4% | +11.7% | +16.0% | +10.5% | +17.5% | +13.1% |
| Gross profit | $15.4M | $17.8M | $21.7M | $24.9M | $30.9M | $35.9M | $43.1M | $47.9M | $43.2M | $46.2M |
| Gross margin | 77.0% | 73.9% | 73.1% | 73.4% | 74.4% | 77.2% | 79.9% | 80.5% | 61.6% | 58.4% |
| Operating income | $7.23M | $8.26M | $10.3M | $10.6M | $11.6M | $11.3M | $14.9M | $8.72M | $6.13M | −$70.7M |
| Operating margin | 36.2% | 34.2% | 34.7% | 31.3% | 27.9% | 24.2% | 27.7% | 14.6% | 8.8% | −89.3% |
| Net income | $4.95M | $5.79M | $8.93M | $8.58M | $9.33M | $9.78M | $12.5M | $9.96M | $9.95M | −$64.7M |
| Net margin | 24.8% | 24.0% | 30.1% | 25.3% | 22.4% | 21.1% | 23.2% | 16.7% | 14.2% | −81.7% |
| EPS (diluted) | $0.29 | $0.33 | $0.50 | $0.48 | $0.50 | $0.47 | $0.60 | $0.49 | $0.49 | −$3.22 |
| Balance sheet | ||||||||||
| Cash and equivalents | $8.03M | $6.22M | $9.40M | $11.4M | $49.2M | $37.0M | $51.6M | $57.5M | $10.3M | $30.9M |
| Total assets | $27.8M | $38.5M | $43.3M | $45.2M | $168.4M | $180.0M | $188.4M | $186.1M | $196.6M | $131.9M |
| Total liabilities | $5.08M | $12.7M | $11.4M | $7.52M | $12.4M | $14.2M | $10.1M | $16.1M | $14.2M | $7.13M |
| Long-term debt | — | $5.74M | $3.33M | — | — | — | — | — | — | — |
| Shareholders' equity | $22.7M | $25.8M | $31.9M | $37.7M | $156.0M | $165.8M | $178.2M | $170.0M | $182.4M | $124.8M |
| Cash flow | ||||||||||
| Operating cash flow | $5.42M | $6.88M | $9.29M | $11.6M | $10.9M | $19.2M | $17.9M | $21.9M | $13.3M | $18.1M |
| Capital expenditure | $39.1K | $176.0K | $183.3K | $138.0K | $231.0K | $1.63M | $819.0K | $453.0K | $566.0K | $713.0K |
| Free cash flow | $5.38M | $6.70M | $9.10M | $11.5M | $10.7M | $17.6M | $17.1M | $21.4M | $12.8M | $17.4M |
| Dividends paid | $3.41M | $3.45M | $4.16M | $4.20M | $4.25M | $4.81M | $4.85M | $4.81M | $4.80M | $0 |
| Share buybacks | — | — | — | — | — | $0 | $0 | $20.0M | $0 | $0 |
RevenueNet incomeNet margin (right axis, %)
| Q4 FY24†Aug 2024 | Q1 FY25Nov 2024 | Q2 FY25Feb 2025 | Q3 FY25May 2025 | Q4 FY25†Aug 2025 | Q1 FY26Nov 2025 | Q2 FY26Feb 2026 | Q3 FY26May 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $18.7M | $18.9M | $22.4M | $20.4M | $17.5M | $18.4M | $24.3M | $21.9M |
| Growth (year over year) | +19.4% | +30.5% | +22.5% | +9.8% | −6.5% | −2.7% | +8.3% | +7.5% |
| Gross profit | $6.83M | $10.2M | $13.1M | $13.0M | $9.84M | $10.9M | $16.1M | $15.1M |
| Gross margin | 36.6% | 54.0% | 58.5% | 64.0% | 56.4% | 59.1% | 66.5% | 69.1% |
| Operating income | −$1.15M | $126.0K | $2.71M | −$74.2M | $659.0K | $713.0K | $5.63M | $4.50M |
| Operating margin | −6.2% | 0.7% | 12.1% | −364.5% | 3.8% | 3.9% | 23.2% | 20.6% |
| Net income | $843.0K | $206.0K | $3.07M | −$67.3M | −$681.0K | $676.0K | $4.54M | $3.58M |
| Net margin | 4.5% | 1.1% | 13.7% | −330.6% | −3.9% | 3.7% | 18.7% | 16.3% |
| EPS (diluted) | $0.04 | $0.01 | $0.15 | −$3.35 | −$0.03 | $0.03 | $0.22 | $0.18 |
| Balance sheet | ||||||||
| Cash and equivalents | $10.3M | $6.19M | $11.0M | $26.9M | $30.9M | $30.2M | $25.7M | $35.3M |
| Total assets | $196.6M | $196.9M | $201.4M | $134.4M | $131.9M | $137.8M | $146.5M | $153.0M |
| Total liabilities | $14.2M | $12.2M | $11.9M | $10.6M | $7.13M | $10.7M | $12.7M | $13.9M |
| Shareholders' equity | $182.4M | $184.7M | $189.5M | $123.8M | $124.8M | $127.1M | $133.8M | $139.0M |
| Cash flow | ||||||||
| Operating cash flow | $1.66M | −$1.27M | $5.67M | $8.14M | $5.59M | $4.23M | $6.41M | $8.71M |
| Capital expenditure | $16.0K | $86.0K | $66.0K | $297.0K | $264.0K | $0 | $46.0K | $93.0K |
| Free cash flow | $1.65M | −$1.36M | $5.60M | $7.85M | $5.32M | $4.23M | $6.37M | $8.62M |
| Dividends paid | $1.20M | $0 | $0 | $0 | $0 | — | — | — |
| Share buybacks | $0 | — | — | — | — | — | — | — |
From Simulations Plus Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in August. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Simulations Plus Inc
- Headquarters
- Durham, North Carolina From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International